Shirit Einav
10Patents
1h-index
19Co-inventors
47Inventor score
Filing activity: Aug 18, 2004 → Aug 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9101628B2 | Methods and composition of treating a flaviviridae family viral infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US10869873B2 | Methods and compositions for treating viral diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US9061010B2 | Methods of treating a Flaviviridae family viral infection and compositions for treating a Flaviviridae family viral infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US7582428B2 | Methods and compositions for identifying anti-HCV agents | Physics | 0 | Expired |
| US9364484B2 | Methods and compositions for treating viral diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US8871435B2 | Methods and compositions for identifying agents that inhibit an NS4B-mediated neoplastic cellular phenotype of HCV infected cells | Human Necessities | 0 | Active |
| US9822127B2 | GAK modulators as antivirals | Chemistry; Metallurgy | 0 | Active |
| US8895598B2 | Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US12161890B2 | Antibodies against dengue virus and related methods | Physics | 0 | Active |
| US9149463B2 | Methods and compositions of treating a Flaviviridae family viral infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.